Ani Pharmaceuticals (ANIP) Change in Intangibles (2013 - 2026)

Ani Pharmaceuticals has disclosed Change in Intangibles across 14 years of filings, most recently posting $5.2 million for Q1 2026.

• Change in Intangibles for Q1 2026 came in at $5.2 million, down 69.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.4 million (down 53.76% YoY), and the FY2025 annual result was $20.5 million, up 2757.18% from the prior year.
• Change in Intangibles came in at $5.2 million for Q1 2026 at Ani Pharmaceuticals, up from $159000.0 in the prior quarter.
• In the past five years, Change in Intangibles ranged from a high of $17.4 million in Q1 2025 to a low of $4000.0 in Q4 2022.
• The 5-year median for Change in Intangibles is $1.6 million (2023), against an average of $3.1 million.
• Peak annual rise in Change in Intangibles reached 62400.0% in 2023, while the deepest fall reached 98.25% in 2023.
• Ani Pharmaceuticals' Change in Intangibles stood at $4000.0 in 2022, then surged by 62400.0% to $2.5 million in 2023, then slumped by 96.56% to $86000.0 in 2024, then surged by 84.88% to $159000.0 in 2025, then surged by 3201.89% to $5.2 million in 2026.
• The last three Change in Intangibles figures came in at $5.2 million (Q1 2026), $159000.0 (Q4 2025), and $60000.0 (Q3 2025), per Business Quant data.